Chlamydia pneumoniae decreases smooth muscle cell proliferation through induction of prostaglandin E2 synthesis

Infection and Immunity

Volumn 72, Issue 8, 2004, Pages 4900-4904

  Rödel, Jürgen ^a   Prochnau, Dirk ^a   Prager, Katrin ^a   Baumert, Jürgen ^a   Schmidt, Karl Hermann ^a   Straube, Eberhard ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2 INHIBITOR; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; PROSTAGLANDIN E2;

ARTICLE; ATHEROSCLEROTIC PLAQUE; BACTERIAL VIRULENCE; BACTERIUM CULTURE; CELL PROLIFERATION; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; CULTURE MEDIUM; HUMAN; HUMAN CELL; MITOGENICITY; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; SMOOTH MUSCLE FIBER; UPREGULATION;

CELL DIVISION; CELLS, CULTURED; CHLAMYDOPHILA PNEUMONIAE; CULTURE MEDIA, CONDITIONED; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; HUMANS; MYOCYTES, SMOOTH MUSCLE; NITROBENZENES; SULFONAMIDES; UP-REGULATION;

EID: 3342875537     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.72.8.4900-4904.2004     Document Type: Article

References (26)

1. Boman, J., and M. R. Hammerschlag. 2002. Chlamydia pneumoniae and atherosclerosis: critical assessment of diagnostic methods and relevance to treatment studies. Clin. Microbiol. Rev. 15:1-20.
2. 2-dependent plaque instability. Circulation 104:921-927.
3. Coombes, B. K., and J. B. Mahony. 1999. Chlamydia pneumoniae infection of human endothelial cells induces proliferation of smooth muscle cells via an endothelial cell-derived soluble factor(s). Infect. Immun. 67:2909-2915.
4. Coombes, B. K., B. Chiu, I. W., Fong, and J. B. Mahony. 2002. Chlamydia pneumoniae infection of endothelial cells induces transcriptional activation of platelet-derived growth factor-B: a potential link to intimal thickening in a rabbit model of atherosclerosis. J. Infect. Dis. 185:1621-1630.
5. Dhume, A. S., and D. K. Agrawal. 2003. Inability of vascular smooth muscle cells to proceed beyond S phase of cell cycle, and increased apoptosis in symptomatic carotid artery disease. J. Vasc. Surg. 38:155-161.
6. Ezzahiri, R., F. R. M. Stassen, H. A. J. M. Kurvers, M. M. L. van Pul, P. J. E. H. M. Kitslaar, and C. A. Bruggeman. 2003. Chlamydia pneumoniae infection induces an unstable atherosclerotic plaque phenotype in LDL-receptor, ApoE double knockout mice. Eur. J. Vasc. Endovasc. Surg. 26:88-95.
7. Futaki, N., S. Takahashi, M. Yokoyama, I. Arai, S. Higuchi, and S. Otomo. 1994. NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro. Prostaglandins 47:55-59.
8. Gouni-Berthold, I., and A. Sachinidis. 2002. Does the coronary risk factor low density lipoprotein alter growth and signalling in vascular smooth muscle cells? FASEB J. 16:1477-1487.
9. Jahn, H. U., M. Krüll, F. N. Wuppermann, A. C. Klucken, S. Rosseau, J. Seybold, J. H. Hegemann, C. A. Jantos, and N. Suttorp. 2000. Infection and activation of airway epithelial cells by Chlamydia pneumoniae. J. Infect. Dis. 182:1678-1687.
10. Kozaki, K., W. E. Kaminski, J. Tang, S. Hollenbach, P. Lindhal, C. Sullivan, J.-C. Yu, K. Abe, P. J. Martin, R. Ross, C. Betsholtz, N. A. Giese, and E. W. Raines. 2002. Blockade of platelet-derived growth factor or its receptors transiently delays but does not prevent fibrous cap formation in ApoE null mice. Am. J. Pathol. 161:1395-1407.
11. Libby, P. 2000. Changing concepts of atherogenesis. J. Intern. Med. 247: 349-358.
12. Libby, P., S. J. Warner, and G. B. Friedman. 1988. Interleukin 1: a mitogen for human vascular smooth muscle cells that induces the release of growth-inhibitory prostanoids. J. Clin. Investig. 81:487-498.
13. Mahony, J. B., and B. K. Coombes. 2001. Chlamydia pneumoniae and atherosclerosis: does the evidence support a causal or contributory role? FEMS Microbiol. Lett. 197:1-9.
14. Newby, A. C., and A. B. Zaltsman. 2000. Molecular mechanisms in intimal hyperplasia. J. Pathol. 190:300-309.
15. Padró, T., R. M. Mesters, B. Dankbar, H. Hintelmann, R. Bieker, M. Kiehl, W. E. Berdel, and J. Kienast. 2002. The catalytic domain of endogenous urokinase-type plasminogen activator is required for the mitogenic activity of platelet-derived and basic fibroblast growth factors in human vascular smooth muscle cells. J. Cell Sci. 115:1961-1971.
16. Proudfoot, D., C. Fitzsimmons, J. Torzewski, and D. E. Bowyer. 1999. Inhibition of human arterial smooth muscle cell growth by human monocyte/macrophages: a co-culture study. Atherosclerosis 145:157-165.
17. Rödel, J., D. Prochnau, K. Prager, E. Pentcheva, M. Hartmann, and E. Straube. 2003. Increased production of matrix metalloproteinases 1 and 3 by smooth muscle cells upon infection with Chlamydia pneumoniae. FEMS Immunol. Med. Microbiol. 38:159-164.
18. Rödel, J., M. Woytas, A. Groh, K.-H. Schmidt, M. Hartmann, M. Lehmann, and E. Straube. 2000. Production of basic fibroblast growth factor and interleukin 6 by human smooth muscle cells following infection with Chlamydia pneumoniae. Infect. Immun. 68:3635-3641.
19. Sasu, S., D. LaVerda, N. Qureshi, D. T. Golenbock, and D. Beasley. 2001. Chlamydia pneumoniae and chlamydial heat shock protein 60 stimulate proliferation of human vascular smooth muscle cells via toll-like receptor 4 and p44/p42 mitogen-activated protein kinase activation. Circ. Res. 89:244-250.
20. Selzman, C. H., M. G. Netea, M. A. Zimmermann, A. Weinberg, L. L. Reznikov, F. I. Grover, and C. A. Dinarello. 2003. Atherogenic effects of Chlamydia pneumoniae: refuting the innocent bystander hypothesis. J. Thorac. Cardiovasc. Surg. 126:688-693.
21. Shah, P. K. 2003. Mechanisms of plaque vulnerability and rupture. J. Am. Coll. Cardiol. 41:15S-22S.
22. Sukhova, G. K., U. Schönbeck, E. Rabkin, F. J. Schoen, A. R. Poole, R. C. Billinghurst, and P. Libby. 1999. Evidence for increased collagenolysis by interstitial collagenases-1 and -3 in vulnerable human atheromatous plaques. Circulation 99:2503-2509.
23. 2 synthesis in abdominal aortic aneurysms: implications for smooth muscle cell viability, inflammatory processes, and the expansion of abdominal aortic aneurysms. Circulation 100:48-54.
24. 2-induced growth inhibition in arterial smooth muscle cells. J. Biol. Chem. 276:34206-34212.
25. Yamashita, K., K. Ouchi, M. Shirai, T. Gondo, T. Nakazawa, and H. Itoh. 1998. Distribution of Chlamydia pneumoniae infection in the atherosclerotic carotid artery. Stroke 29:773-778.
26. 2 synthesis and attenuates chlamydial growth. J. Med. Microbiol. 52:409-415.